Jaffetilchin Investment Partners, LLC Abb Vie Inc. Transaction History

Jaffetilchin Investment Partners, LLC

$1.1 Billion
Q1 2024

A detailed history of Jaffetilchin Investment Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jaffetilchin Investment Partners, LLC holds 10,551 shares of ABBV stock, worth $1.75 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

10,551

Previous 13,820 23.65%

Holding current value

$1.75 Million

Previous $2.14 Million 10.28%

% of portfolio

0.17%

Previous 0.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	SELL	$159.82 - $182.1 $522,451 - $595,284	-3,269 Reduced 23.65%	10,551 $1.92 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $67,974 - $76,555	494 Added 3.71%	13,820 $2.14 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $330,100 - $382,140	2,471 Added 22.76%	13,326 $1.99 Million
Q2 2023 Aug 15, 2023	SELL	$132.51 - $164.9 $70,230 - $87,397	-530 Reduced 4.66%	10,855 $1.46 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $527,971 - $608,037	3,651 Added 47.21%	11,385 $1.81 Million

Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $274,407 - $329,086	1,984 Added 34.5%	7,734 $1.25 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $420,077 - $481,800	-3,130 Reduced 35.25%	5,750 $772,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $33,304 - $42,340	242 Added 2.8%	8,880 $1.36 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $103,736 - $128,707	-786 Reduced 8.34%	8,638 $1.33 Million
Q4 2021 Feb 17, 2022	SELL	$107.43 - $135.93 $67,036 - $84,820	-624 Reduced 6.21%	9,424 $1.28 Million
Q3 2021 Oct 25, 2021	SELL	$106.4 - $120.78 $15,002 - $17,029	-141 Reduced 1.38%	10,048 $1.08 Million
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $110,049 - $122,601	1,046 Added 11.44%	10,189 $1.15 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $352,730 - $388,313	3,448 Added 60.54%	9,143 $989,000
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $199,534 - $269,392	2,479 Added 77.08%	5,695 $610,000
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $320,272 - $375,894	-3,728 Reduced 53.69%	3,216 $282,000
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $463,698 - $620,497	6,320 Added 1012.82%	6,944 $682,000
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $45,782 - $61,264	624 New	624 $682,000
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $158,347 - $240,074	-2,455 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $177,079 - $221,563	2,455 New	2,455 $217,000
Q3 2018 Oct 05, 2018	SELL	$88.91 - $98.84 $1.08 Million - $1.2 Million	-12,131 Closed	0 $0
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $667,155 - $789,395	7,431 Added 158.11%	12,131 $1.12 Million
Q1 2018 Apr 20, 2018	SELL	$92.01 - $123.21 $1.1 Million - $1.47 Million	-11,966 Reduced 71.8%	4,700 $445,000
Q4 2017 Jan 10, 2018	BUY	$89.56 - $98.21 $302,712 - $331,949	3,380 Added 25.44%	16,666 $1.61 Million
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $928,027 - $1.19 Million	13,286	13,286 $1.18 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.

Account

Jaffetilchin Investment Partners, LLC Abb Vie Inc. Transaction History